glp-1 anhedonia medications are known for reducing appetite — but for some patients, the effects may go beyond food., A growing concern is emotional blunting (anhedonia), where people report feeling less joy, GLP‐1 Receptor Agonists for Treating

Is your organization looking for a scalable, science-based way to address obesity and cardiometabolic disease

In the past, drug design and delivery were separate stages, but now companies can think about both upfront

In 2019 and 2020, a formulation of Semaglutide (brand name Rybelsus) was approved as a daily oral medication for treating diabetes, when used along with diet and exercise

Discoveries of clinical benefits or their underlying mechanisms are not patentable but may suggest patentable uses or formulations

Summary of included studies regarding the adverse psychiatric outcomes associated with GLP-1-RAs)

Semaglutide has a half-life of approximately 7 days, which is why it works as a once-weekly injection